{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:51:17Z","timestamp":1791352277508,"version":"4.3.1"},"reference-count":30,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2009,6,11]],"date-time":"2009-06-11T00:00:00Z","timestamp":1244678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> To investigate the putative association between isotretinoin treatment and depressive symptoms or suicidal ideation among Finnish male military conscripts.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Consecutive acne patients were enrolled into an uncontrolled, prospective 12\u2010week follow\u2010up study conducted at the Central Military Hospital, Helsinki, Finland. Of the 135 patients prescribed isotretinoin, 126 (93.3%) completed the follow\u2010up. Depression and suicidal ideation were investigated with the Beck Depression Inventory (BDI) at baseline, weeks 4\u20136, and weeks 10\u201312.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> BDI mean score was low at baseline and declined further significantly (<jats:italic>p<\/jats:italic>\u00a0&lt; 0.001) during the follow\u2010up from 3.0 (SD 3.948) to 1.8 (SD 3.783) among patients on isotretinoin. Moreover, the proportion of patients with clinically significant depressive symptoms (BDI\u00a0\u2265\u00a010) declined non\u2010significantly from 7.1 % to 3.2 %. Suicidal ideation was reported by 17 (13.5 %) patients at baseline and 9 (7.1%) patients at the end of the follow\u2010up (NS). During the follow\u2010up, one non\u2010depressed patient attempted suicide while intoxicated by alcohol.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> On group level, isotretinoin seems not to be typically associated with treatment\u2010emergent depression or suicidal ideation among young men. However, the possibility that individual patients may be susceptible for mood effects of isotretinoin as a rare idiosyncratic reaction can not be excluded.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2009.03313.x","type":"journal-article","created":{"date-parts":[[2009,6,12]],"date-time":"2009-06-12T04:04:58Z","timestamp":1244779498000},"page":"1294-1297","source":"Crossref","is-referenced-by-count":51,"title":["Depressive symptoms and suicidal ideation during isotretinoin treatment: a 12\u2010week follow\u2010up study of male Finnish military conscripts"],"prefix":"10.1111","volume":"23","author":[{"given":"LMH","family":"Rehn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Meririnne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"H\u00f6\u00f6k\u2010Nikanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Isomets\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Henriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,10,8]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0790966700003530"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)81018-3"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(83)80154-6"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200501000-00008"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2005.11.006"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.117730"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.07.001"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.5.983"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2466\/PR0.99.3.897-906","article-title":"Incidence of depression related to isotretinoin treatment in 100 acne vulgaris patients","volume":"99","author":"Kaymak Y","year":"2006","journal-title":"Psychol Reports"},{"key":"e_1_2_6_11_2","first-page":"484","article-title":"A prospective study of the responsiveness of depression and suicidal ideation in acne patients to different phases of isotretinoin therapy","volume":"15","author":"Kellett SC","year":"2005","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630410027472"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02662.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70166-2"},{"key":"e_1_2_6_15_2","first-page":"e227","article-title":"No association found between patients receiving isotretinoin for acne and the development of depression in a Canadian prospective cohort","volume":"14","author":"Cohen J","year":"2007","journal-title":"Can J Clin Pharmacol"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.5.557"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-0960.2002.00612.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)02087-5"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.10.1231"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0403"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02514.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1961.01710120031004"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.3109\/09546639809160698"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2004.00946.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2000.00907.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291704003770"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1996.tb09855.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.6.1093"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1521\/suli.2005.35.3.239"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23621.x"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2009.03313.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2009.03313.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T22:41:58Z","timestamp":1697064118000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2009.03313.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,8]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1111\/j.1468-3083.2009.03313.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03313.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,8]]}}}